Drawing for RNAI THERAPEUTICS

USPTO serial 76579733

RNAI THERAPEUTICS

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
Examiner
STINE, DAVID
Law office
PETITIONS OFFICE

What this means

These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.

Status 602: These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances.

Need help with RNAI THERAPEUTICS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
001Diagnostic preparations for scientific and research use, namely, preparations containing synthetic nucleic acid, including synthetic DNA, cloned DNA and recombinant DNA; synthetic RNA, cloned RNA and recombinant RNA; DNA and RNA for scientific and research use in the fields of agricultural and industrial biotechnology use; DNA and RNA and preparations containing DNA and/or RNA for scientific and research use in the regulation and/or expression of mammalian (including human), plant, microbial and synthetic genes for use in the fields of pharmaceutical research and agricultural and industrial biotechnology; pharmaceutical and other diagnostic preparations for scientific and research use in the fields of agricultural and industrial biotechnology; pharmaceutical and other preparations for use in the field of pharmaceutical research; yeast, fungi, tissue culture of plants, and genetically modified examples thereof for scientific or research useACTIVE
005Diagnostic preparations for clinical and medical and/or veterinary laboratory use, namely, DNA and/or RNA and preparations containing DNA and/or RNA for the regulation and expression of mammalian (including human), plant, microbial and synthetic genes for use in the fields of human and veterinary therapeutics; medicinal and biological preparations for clinical or medical laboratory use including preparations for the modification of gene expression; medicinal and biological preparations for pharmaceutical use in the treatment of viral infections and viral associated diseases, cancers, autoimmune diseases, central nervous system disorders and all other diseases and/or conditions that RNA interference can be used to diagnose and/or treat; pharmaceutical and other preparations for use in the fields of human and veterinary therapeutics in the treatment of viral infections and viral associated diseases, cancers, autoimmune diseases, central nervous system disorders and all other diseases and/or conditions that RNA interference can be used to diagnose and/or treatACTIVE
031Live plants, parts of live plants, cuttings of live plants and genetically modified examples thereof; plant seeds and plant seeds that are genetically modified; live animals and live animals that are genetically modifiedACTIVE

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (ARAA): This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.

DateCodeEventWhat it means
Jun 29, 2006ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 29, 2006REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Apr 27, 2005MAB2ABANDONMENT NOTICE MAILED - FAILURE TO RESPONDThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Apr 27, 2005ABN2ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSEThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Sep 29, 2004CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 28, 2004CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 28, 2004CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 22, 2004DOCKASSIGNED TO EXAMINER
Mar 22, 2004NWAPNEW APPLICATION ENTERED

Frequently asked questions

Related guidance